Will AstraZeneca be able to provide clinical trial data on its COVID‐19 vaccine efficacy in older adults?

Keywords: AstraZeneca vaccine; COVID-19; efficacy; elderly; placebo-controlled trials; SARS-CoV-2 EN AstraZeneca vaccine COVID-19 efficacy elderly placebo-controlled trials SARS-CoV-2 2405 2406 2 04/30/21 20210501 NES 210501 The UK MHRA granted emergency authorization to the AstraZeneca COVID-19 vaccine on December 30, 2020. Will AstraZeneca be able to provide clinical trial data on its COVID-19 vaccine efficacy in older adults? However, vaccine effectiveness in the real world - that could be shown in observational studies conducted in countries where this vaccine is being rolled out10 - will shed light on this weak point of this, otherwise, cheap and useful vaccine to address this pandemic. [Extracted from the article]